October 25, 2014 10:17 PM ET

Life Sciences Tools and Services

Company Overview of Myriad RBM, Inc.

Company Overview

Myriad RBM, Inc., a multiplexed immunoassay testing laboratory, provides protein biomarker services based on its multi-analyte profiling technology platform. It offers reproducible and quantitative multiplexed immunoassay data for various proteins from a single drop of blood serum or plasma to clinical researchers and healthcare providers to advance their drug development and patient care. The company's products and services include Human MAPs that provide insight into various pathways to understand the underlying biology; Rodent MAPs that provide quantitative measurement of biomarkers enabling new pattern discovery, and sensitive safety and efficacy assessments; and Canine KidneyMAP service...

3300 Duval Road

Austin, TX 78759

United States

Founded in 2002

141 Employees





Key Executives for Myriad RBM, Inc.

Age: 59
Chief Financial Officer
Age: 51
Chief Medical Officer
Age: 61
Managing Director of Communications
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.

Myriad RBM, Inc. Key Developments

Institut Pasteur and Myriad RBM Publish Initial Results from Study of Immune Response

Institut Pasteur and Myriad RBM announced they have published an initial data analysis from the Milieu Interieur Project in the journal Immunity, which provided new insights into the healthy human immune response. The Milieu Interieur project is a population-based study supported by the French National Ministry of Research and coordinated by the Institut Pasteur, Paris that will characterize the immune phenotypes of 1,000 healthy subjects. The results could lead to the development of novel diagnostics and companion diagnostics. In the paper titled, 'Functional Analysis using Standardized Whole Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli,' the authors describe the use of Myriad RBM's TruCulture(r) technology, a proprietary blood collection and culturing system, to characterize individual immune responses of 25 healthy people to medically relevant stimuli. Unlike the current laboratory-based methods, TruCulture is deployed at the site of collection and therefore avoids variability from shipping and complex processing as well as the expense of a cell culture facility and staff. The results in the Immunity paper show that TruCulture stimulations are reproducible, with close correspondence in repeated tests from the same subject.

DVA Laboratory Services, Inc. and Myriad RBM, Inc. Announce Biomarker Research Collaboration

DVA Laboratory Services, Inc. and Myriad RBM announced a research collaboration to conduct protein biomarker discovery research with the goal of developing and commercializing diagnostic tests that could benefit in the treatment of dialysis patients. DaVita and Myriad have identified potential opportunities where novel diagnostic tests utilizing blood-based protein biomarkers could improve the quality of life for patients and potentially lower overall healthcare costs. The primary area of focus will include the prediction of vascular access failure.

Similar Private Companies By Industry

Company Name Region
Covance Clinical Research Unit, Inc. United States
Reliable Research Laboratory Inc. United States
BioStorage Technologies, Inc. United States
Novum Pharmaceutical Research Services Of Nevada, Inc. United States
CHDI Foundation, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Myriad RBM, Inc., please visit rbm.myriad.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.